GARNET JEAN BLATCHFORD, MD

OMAHA, NE

Research Active
Colon & Rectal Surgery NPI registered 21+ years 6 publications 1983 – 2017 NPI: 1790783454
Digestive System Surgical ProceduresRecurrenceOdorantsNitrogenCitiesCarbonSurgical FlapsBioreactorsAmmoniaAnal CanalFecal IncontinenceLigationTreatment FailureAnaerobiosisRectal Fistula

Practice Location

9850 NICHOLAS ST
OMAHA, NE 68114-2186

Phone: (402) 343-1122

What does GARNET BLATCHFORD research?

Dr. Blatchford studies various surgical methods and techniques, specifically looking at improving patient outcomes in surgeries related to anal fistulas and loop ileostomies. His research explores how certain treatments, such as a special membrane called Seprafilm, can prevent complications during surgeries. Additionally, he investigates innovative methods for treating wastewater, which help address environmental concerns like ammonia management and air quality improvement.

Key findings

  • In a study of 53 patients with anal fistula treatments, 38% still had their fistula after a LIFT procedure, while half of those found healing after further surgery.
  • The introduction of a nitrification system in wastewater treatment reduced harmful hydrogen sulfide emissions, ultimately saving $310.
  • Using Seprafilm in loop ileostomy closure reduced adhesion rates from 95.2% to 82.3%, which can lead to safer surgeries.

Frequently asked questions

Does Dr. Blatchford study anal fistulas?
Yes, Dr. Blatchford examines the outcomes and challenges faced by patients with anal fistulas, particularly after the LIFT treatment.
What surgical treatments has Dr. Blatchford researched?
He has researched treatments for anal fistulas and loop ileostomy closures, including the use of Seprafilm to reduce complications.
Is Dr. Blatchford's work relevant to environmental issues?
Absolutely, he has developed innovative methods for treating wastewater that improve community health and environmental standards.

Publications in plain English

What happens after a failed LIFT for anal fistula?

2017

American journal of surgery

Wright M, Thorson A, Blatchford G, Shashidharan M, Beaty J +4 more

Plain English
This study examined what happens to patients after their anal fistula treatment using a method called LIFT fails. Out of 53 patients, 20 (about 38%) still had their fistula after the procedure, and half of them found success in healing after additional surgeries. This is important because it highlights the challenges faced by patients with persistent issues after LIFT and the possible effectiveness of follow-up treatments. Who this helps: This helps patients suffering from anal fistulas and the doctors treating them.

PubMed

Discussion of: "What happens after a failed LIFT for anal fistula?".

2017

American journal of surgery

Wright M, Thorson A, Blatchford G, Shashidharan M, Beaty J +4 more

PubMed

Innovative approach to centrate nitrification accomplishes multiple goals: nitrogen removal and odour control.

2010

Water science and technology : a journal of the International Association on Water Pollution Research

Husband JA, Phillips J, Coughenour JR, Walz T, Blatchford G

Plain English
The study explored a new method for treating wastewater in Phoenix, Arizona, by improving how ammonia is handled in the process of turning waste into safe materials. Researchers found that by adding a nitrification system, the treatment plant effectively managed ammonia levels while reducing harmful hydrogen sulfide emissions, saving around $310. This is important because it helps meet environmental regulations and improves air quality. Who this helps: This benefits the community and the environment.

PubMed

Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure?

2006

Techniques in coloproctology

Salum M, Wexner SD, Nogueras JJ, Weiss E, Koruda M +28 more

Plain English
This study looked at whether using a special membrane called Seprafilm helps reduce complications and the time it takes to close a loop ileostomy, a type of surgery. They found that while Seprafilm reduced the number of patients with adhesions (95.2% in the control group without Seprafilm vs. 82.3% in the group with it), the overall surgery time was similar across all groups, averaging around 27-28 minutes. This matters because reducing adhesions can make surgeries safer and easier, even if it doesn’t change the length of surgery. Who this helps: Patients undergoing loop ileostomy closure.

PubMed

Medical care in hospice day care.

1993

Journal of palliative care

Sharma K, Oliver D, Blatchford G, Higginbottom P, Khan V

PubMed

Paget's disease of the breast.

1983

The Nebraska medical journal

Thorson AG, Karrer FW, Moor BJ, Rose SG, Blatchford G +1 more

PubMed

Frequent Co-Authors

Moriah Wright Alan Thorson Maniamparampil Shashidharan Jennifer Beaty Noelle Bertelson Piyush Aggrawal Lindsay Taylor Charles A Ternent Joseph A Husband Jennifer Phillips

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.